Latest News
- Research led by UCLA’s Jonsson Comprehensive Cancer Center tests cost-effective approach to early-cancer detection from cell-free DNA in blood samples
UCLA researchers and collaborating organizations report successful results from an experimental cancer-detection system that appears to have overcome these challenges in a novel, cost-effective way.
September 23, 2022 10:00 AM
detail - Cell therapy could improve bone marrow transplant safety
UCLA researchers report a step forward in the development of an “off-the-shelf” cell therapy that could reduce the severity of graft-versus-host disease in people receiving donor bone marrow transplants for the treatment of blood cancers such as leukemia and lymphoma.
September 12, 2022 9:00 AM
detail - Antoni Ribas receives renewal of NCI Outstanding Investigator Award
Dr. Antoni Ribas has received a renewal of an Outstanding Investigator Award from the National Cancer Institute to fund his innovative research on metastatic melanoma.
September 07, 2022 9:00 AM
detail - Colorectal cancer screening initiative from Stand Up to Cancer, collaborators wins Los Angeles Business Journal health care award
An ambitious joint initiative by Stand Up To Cancer® to improve colorectal cancer screening and treatment in medically underserved communities across Los Angeles was recognized today with a Health Care Leadership Award by the Los Angeles Business Journal.
August 31, 2022 6:00 AM
detail - UCLA Health organizes relief for Ukrainian cancer patients and refugees
This summer, UCLA Health sent two shipments of cancer drugs and supplies to Ukraine for patients desperately in need.
August 31, 2022 6:00 AM
detail - Researchers examine link between pesticides and thyroid cancer risk in Central California area
In single pollutant models and within a 20-year period, 10 out of 29 reviewed pesticides were associated with thyroid cancer, including several of the most widely used ones in the U.S. These included paraquat dichloride, glyphosate and oxyfluorfen.
August 18, 2022 6:00 AM
detail - Determining how nucleoside metabolism regulates contrasting immune functions in the rare disease PNP deficiency
Results from a new UCLA study help inform the design of approaches to treat PNP insufficiency in humans as well as new therapeutic applications for clinical-stage PNP inhibitors.
August 15, 2022 6:00 AM
detail - PET scan visualization can measure effects of STING-activating drugs and could help guide clinical development of this potential anti-tumor therapy
Findings from a new UCLA study reveal previously unknown functional links between STING signaling and immunometabolism, and also suggests that PET imaging could provide a widely accessible approach to measure the effects of STING-activating drugs.
August 12, 2022 9:00 AM
detail - Improve lung cancer outcomes with low-dose CT screening
While not all lung cancers are caused by cigarette smoking, quitting the habit—or never starting—is an important part of cancer prevention. For high-risk current and former smokers, lung cancer screening and early detection can significantly improve outcomes.
August 09, 2022 9:00 AM
detail - UCLA researchers awarded Department of Defense funding to improve prostate cancer treatment outcomes
A UCLA team led by Dr. Paul Boutros has been awarded over $2.7 million in research funding from the U.S. Department of Defense to support two projects that will use computational models and DNA sequencing to improve prostate cancer treatment outcomes.
July 22, 2022 11:00 AM
detail - Cancer genetic counseling comes into its own at UCLA
About ten percent of cancers are caused by inherited mutations, and learning whether an individual has such mutations can help patients, families and health care providers make informed choices about managing a cancer diagnosis or elevated cancer risk.
July 21, 2022 6:00 AM
detail - RNA may be an informative biomarker for head and neck cancer treatment, UCLA study says
Liquid biopsies for certain cancers are gaining popularity because they’re less invasive than traditional ones. They can be used to monitor cancer treatment, providing physicians a way to reliably check to see whether that treatment is working.
July 15, 2022 6:00 AM
detail - NEJM editorial by UCLA’s Sara Hurvitz: DESTINY-Breast04 results are ‘practice-changing’
A Phase 3 trial showing positive results for a drug given to breast cancer patients who have low levels of the HER2 protein is “immediately practice-changing,” UCLA’s Sara A. Hurvitz, MD, writes in an editorial published in The New England Journal of Medicine.
July 07, 2022 6:00 AM
detail - UCLA Health earns Comprehensive Center of Excellence designation for radiopharmaceutical therapy as work continues on new facility
UCLA Health’s Ahmanson Translational Theranostics Division has been designated a Comprehensive Radiopharmaceutical Therapy Center of Excellence by the Society of Nuclear Medicine & Molecular Imaging (SNMMI).
June 30, 2022 9:00 AM
detail